Privia Health (PRVA) Cash from Financing Activities (2020 - 2026)

Privia Health has reported Cash from Financing Activities for 7 years, with the latest figure at $3.0 million in Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 61.39% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was -$5.1 million, a 181.06% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, up 54.64% from the prior year.
• Cash from Financing Activities was $3.0 million for Q2 2026 at Privia Health, up from -$10.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $8.6 million in Q3 2022, with the low at -$30.9 million in Q2 2022.
• Average Cash from Financing Activities over 5 years is -$698166.7, with a median of $1.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities surged 9319.35% in 2022, then slumped 575.7% in 2026.
• Over 5 years, Cash from Financing Activities stood at $2.0 million in 2022, then sank by 97.85% to $42000.0 in 2023, then surged by 1373.81% to $619000.0 in 2024, then surged by 246.53% to $2.1 million in 2025, then jumped by 41.68% to $3.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $3.0 million (Q2 2026), -$10.7 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.